Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (171)
- Scheduling (national classification system) (58)
- Manufacturing (28)
- Advertising (22)
- Unique Device Identification (UDI) hub (21)
- Safety monitoring and information (18)
- Compliance and enforcement (14)
- Clinical trials (10)
- Vaping hub (9)
- Legislation (8)
- Medicinal cannabis hub (5)
- Shortages and supply disruptions (3)
- Breast implant hub (2)
- Cosmetics (1)
- Import and export (1)
- Labelling and packaging (1)
Search
415 result(s) found, displaying 101 to 125
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresentations given by the TGA at the 2023 ARCS Annual Conference, 6-8 June 2023.
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
PresentationsPresented at the 2023 ARCS Annual Conference
-
-
-
-
Committee meetingsAdvisory Committee on Complementary Medicines (ACCM) meeting
-
-
-
WebinarsAustralian UDI update and guest speakers on the value of UDI for procurement and inventory management in hospitals.
-
PresentationsThe TGA Good Manufacturing Practice Forum returned to Sydney on 21 March 2023.
-
PresentationsThis webinar will address the recent announcement by the TGA that medicines containing psilocybin and MDMA will be conditionally classified as Schedule 8 (controlled drug) in the Poisons Standard.
-
WebinarsThis webinar will address the recent announcement by the TGA that medicines containing psilocybin and MDMA will be classified as Schedule 8 (controlled drug) when prescribed by a psychiatrist.
-
WebinarsIn this webinar we will provide an update on the Australian UDI implementation and discuss the challenges and benefits of having UDI in healthcare and the role of hospitals and other healthcare providers in relation to using UDI.